Premier Health of America
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Premier Health of America generated cash of $5,928,000, which is more than the previous year. Cash used in financing activities reached the amount of $20,853,000 last year. Net change in cash is therefore $346,000.
Cash Flow
| 2017 | 211.70K | -343.45K | 140.82K |
|---|---|---|---|
| 2018 | -3.48K | 0 | -79.14K |
| 2019 | -168.13K | -206.58K | 323.50K |
| 2020 | 804.89K | 894.94K | -424.54K |
| 2021 | 1.97M | -16.08M | 15.55M |
| 2022 | 4.04M | -12.66M | 11.06M |
| 2023 | -1.27M | -3.33M | 625K |
| 2024 | 5.92M | -26.43M | 20.85M |
PHA.V Cash Flow Statement (2017 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.14M | 5.12M | 2.68M | 1.23M | -41.01K | 71.37K | 154K | 13.55K |
Operating activities | ||||||||
Net income | -12.48M | -1.70M | -111.50K | 1.49M | 27.92K | -282.84K | -18.42K | 179.39K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 6.81M | 4.44M | 3.42M | 2.46M | 163.91K | 133.37K | 0 | 155.28K |
Stock-based compensation expense | 191K | 311K | 498K | 337.02K | 189.4K | 51.5K | 0 | 0 |
| Deferred income tax benefit | 191K | 311K | 498K | 337.02K | 189.4K | 51.5K | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 15.10M | -3.66M | -2.98M | -2.15M | -1.77M | -443.08K | 0 | -260.59K |
Inventories | 0 | 0 | 0 | 0 | 0 | 215.79K | 0 | 0 |
Accounts payable | -9.42M | -1.74M | 2.43M | 1.01M | 865.36K | 351.95K | 0 | 0 |
Cash generated by operating activities | 5.92M | -1.27M | 4.04M | 1.97M | 804.89K | -168.13K | -3.48K | 211.70K |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -257K | -487K | -657.08K | -1.95M | -325.69K | -89.42K | 0 | -109.55K |
Acquisitions Net | -23.66M | -1.33M | -12.23M | -13.95M | 1.23M | 2.5K | 0 | 0 |
Cash generated by investing activities | -26.43M | -3.33M | -12.66M | -16.08M | 894.94K | -206.58K | 0 | -343.45K |
Financing activities | ||||||||
Common Stock Issued | 0 | 0 | 767K | 7.48M | 151.27K | 382.74K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -128K | -515K | 0 | 0 | 0 | -990 | 0 | 0 |
Repayments of term debt | 20.96M | 1.35M | 10.29M | -14.69M | -530.82K | -373.19K | 0 | 0 |
Cash used in financing activities | 20.85M | 625K | 11.06M | 15.55M | -424.54K | 323.50K | -79.14K | 140.82K |
Net Change In Cash | 346K | -3.97M | 2.44M | 1.44M | 1.27M | 155.36K | -82.62K | 9.07K |
Cash at end of period | 1.49M | 1.14M | 5.12M | 2.68M | 1.23M | 226.73K | 71.37K | 22.62K |